SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roger Cranwill who wrote (1114)7/15/1997 12:26:00 AM
From: m meixlER   of 1762
 
To ALL: one of by clients a retired preacher just bought a large stake
in IDEC--since he is very conservative I asked him about it he told
me his son is a PHD in chemistry and told him about IDEC--I
called his son he works for genentech and worked on this non toxic
chemo drug--he said it really works and that had no questions in his
mind that it would be approved. Also FYI first boston has a research
report with idec as a strong buy with a 43 tgt and an estimated mkt
potential of 300- 400 million for the drug. MM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News